The Alzheimer's gene APOE4 may be damaging brain blood vessels in a way that can be undone
Two Mount Sinai studies, in Cell and Cell Stem Cell, go after the strongest known genetic risk factor for Alzheimer's 2. For the Cell paper, the team stitched existing datasets into a single-cell atlas of the human brain's blood vessels.
In people carrying APOE4, pericytes, the cells that normally steady small vessels and help maintain the blood-brain barrier, turned into myofibroblast-like cells that lay down scar tissue. The result was fibrosis in the vessel wall and more amyloid piling up around it. Then they blocked TGF-β signaling, a channel cells use to talk and remodel tissue. Pericyte coverage came back, and fibrosis and amyloid dropped, including in aged APOE4 mice 2. The second paper describes a stem-cell-derived human brain tissue platform meant to speed up drug testing 2.